AIDS and Behavior

, Volume 23, Issue 1, pp 132–139 | Cite as

Does Quality of Life and Sexual Quality of Life in HIV Patients Differ Between Non-treated HIV Controllers and Treated Patients in the French ANRS VESPA 2 National Survey?

  • Marie PréauEmail author
  • Marion Mora
  • Costanza Puppo
  • Vanessa Laguette
  • Luis Sagaon-Teyssier
  • Faroudy Boufassa
  • Laurence Meyer
  • Olivier Lambotte
  • Bruno Spire
Original Paper


People living with HIV who spontaneously control the virus without antiretroviral treatment are called HIV Controllers and their status places them at the limits of bio-clinical normality. The objective of this study was to investigate an unexplored field: HIV Controllers’ quality of life (QOL). Using quantitative methods, we compared the QOL of untreated (by definition) HIV Controllers in the ANRS CO18 HIV Controller cohort study, with the QOL of treated patients in the French national survey ANRS VESPA 2. In particular, the physical, social, mental and sexual dimensions of QOL were examined. Results highlight that perceiving oneself to be ill or healthy is linked to stigma and to a lack of self-identification with a social group. Some components of the QOL were significantly impaired in HIV controllers. This study is the first to investigate this field.


HIV controllers Quality of life Sexual quality of life Psychosocial 



This study was funded by French Aids National Research Agencies (Grant Number 2012-2).

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


  1. 1.
    Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, et al. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood. 1997;90(3):1133–40.Google Scholar
  2. 2.
    Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41(7):1053–6.Google Scholar
  3. 3.
    Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol. 2007;81(24):13904–15.Google Scholar
  4. 4.
    Sáez-Cirión A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA. 2007;104(16):6776–81.Google Scholar
  5. 5.
    Deeks SG. B.D W. Human immunodeficiency virus controllers. Mechanism of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27(3):406–16.Google Scholar
  6. 6.
    Organization WH. WHOQOL measuring quality of life. Geneva: World Health Organization; 1997.Google Scholar
  7. 7.
    Jasmin C. Cancer and AIDS as a model for the study of quality of life. In: 2nd International Conference of the International-Council-for-Global-Health-Progress. Paris; 1996.Google Scholar
  8. 8.
    Liu C, Johnson L, Ostrow D. Predictors for lower Quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr. 2006;42(4):470–7.Google Scholar
  9. 9.
    Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med. 2001;134:854–60.Google Scholar
  10. 10.
    Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B, et al. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS Lond Engl. 2007;21(Suppl 1):S19–27.Google Scholar
  11. 11.
    Charpentier N, Quatremère G, Mabire X, Roduit S, Laguette V, Spittler D, et al. Freins et leviers de la prise en charge du traitement post-exposition au VIH, Barriers and levers to HIV post-exposure prophylaxis. Santé Publique. 2016;28(6):791–9.Google Scholar
  12. 12.
    Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B, et al. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. London, England: AIDS; 2007.
  13. 13.
    Buseh AG, Kelber ST, Stevens PE, Park CG. Relationship of symptomes, perceived health and stigma with quality of life among urban HIV-infected African. Am Men Public Health Nurs. 2008;25:409–19.Google Scholar
  14. 14.
    Joachim G, Acorn S. Stigma of visible and invisible chronic conditions. J Adv Nurs. 2000;32(1):243–8.Google Scholar
  15. 15.
    Stigmate Goffman E. Les usages sociaux des handicaps. Paris: Le Sens Commun; 1975.Google Scholar
  16. 16.
    Farmer P. AIDS and accusation. Haiti and the geography of blame. Berkeley: University of California Press; 1992.Google Scholar
  17. 17.
    Carricaburu D, Pierret J. From biological disruption to biographical reinforcement: the case of HIV-positive men. Sociol Health Illn. 1995;17(1):65–88.Google Scholar
  18. 18.
    Crossley M. “Sick role” or “empowerment?” The ambiguities of life with an HIV positive diagnosis. Sociol Health Illn. 1998;20(4):507–31.Google Scholar
  19. 19.
    Ciambrone D. Illness and other assaults on self: the relative impact of HIV/AIDS on women’s lives. Sociol Health Illn. 2001;23(4):517–40.Google Scholar
  20. 20.
    Carrieri MP, Villes V, Raffi F, Protopopescu C, Preau M, Salmon D, et al. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8). Int J Drug Policy. 2007;18(4):288–95.Google Scholar
  21. 21.
    Préau M, Bouhnik A-D, Heard I, Brunet-François C, LeMoing V, Collin F, et al. Mental health of HIV-positive women in France in the era of antiretroviral therapies: what differences between men and women? What is at stake?]. Méd Sci MS. 2008;24:151–60.Google Scholar
  22. 22.
    Marcellin F, Préau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials. 2007;8(5):320–7.Google Scholar
  23. 23.
    Diaw J, Taverne B, Coutherut J. Plaintes et dysfonctions sexuelles des personnes vivant avec le VIH (PVVIH), traitées par antirétroviraux (ARV) depuis une dizaine d’année au Sénégal. Bull Soc Pathol Exot. 2014;107(4):258–60.Google Scholar
  24. 24.
    El Fane M, Bensghir R, Sbai S, Chakib A, Kadiri N, Ayouch A, et al. Quality of sexual life for people living with HIV (PLWHA). Sexologies. 2011;20(3):158–62.Google Scholar
  25. 25.
    Amini Lari M, Faramarzi H, Shams M, Marzban M, Joulaei H. Sexual dysfunction, depression and quality of life in patients with HIV infection. Iran J Psychiatry Behav Sci. 2013;7(1):61–8.Google Scholar
  26. 26.
    Bouhnik AD, Préau M, Lert F, Peretti-Watel P, Schiltz MA, Obadia Y, et al. Unsafe sex in regular partnerships among heterosexual persons living with HIV: evidence from a large representative sample of individuals attending outpatients services in France. AIDS. 2007;21(1):57–62.Google Scholar
  27. 27.
    Préau M, Mora M, Laguette V, Colombani C, Boufassa F, Meyer L, et al. Identity, representations and beliefs: HIV controllers living on the frontier of good health and illness. Qual Health Res. 2015;26:1483–94.Google Scholar
  28. 28.
    Dray-Spira R, Spire B, Lert F, Groupe V. General method of the ANRS-VESPA2 study [in French]. Bull Epidemiol Hebdo. 2013;321–324:283–324.Google Scholar
  29. 29.
    Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013–23.Google Scholar
  30. 30.
    Duracinsky M, Lalanne C, Le Coeur S, Herrmann S, Berzins B, Armstrong AR, et al. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J Acquir Immune Defic Syndr. 2012;59(5):506–15.Google Scholar
  31. 31.
    Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41(7):1053–6.Google Scholar
  32. 32.
    McDowell TL, Serovich JM. The effect of perceived and actual social support on the mental health of HIV-positive persons. AIDS Care. 2007;19(10):1223–9.Google Scholar
  33. 33.
    Penrod J. Refinement of the concept of uncertainty. J Adv Nurs. 2001;34(2):238–45.Google Scholar
  34. 34.
    Penrod J. Living with uncertainty: concept advancement. J Adv Nurs. 2007;57(6):658–67.Google Scholar
  35. 35.
    Vincent W, Fang XD, Calabrese SK. HIV-related shame and health-related quality of life among older, HIV-positive adults. J Behav Med. 2017;40(3):434–44.Google Scholar
  36. 36.
    Bozon M. Observer l’inobservable: la description et l’analyse de l’activité sexuelle. Bajos N, Bozon M, Giami, editors. Doré V Souteyrand Sex. 1995;39–56.Google Scholar
  37. 37.
    Tindall B. Sexual dysfunction in advanced HIV disease, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, and Centre for Immunology. St Vincents Hosp Syd Aust. 2007;25:105–7.Google Scholar
  38. 38.
    Troussier T, Tourette-Turgis C. La qualité de la vie sexuelle et affective favorise la prévention chez les personnes vivant avec le VIH. Sexologies. 2006;15(3):165–75.Google Scholar
  39. 39.
    Lamba H, Goldmeier D, Mackie NE, Scullard G. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS. 2004;15(4):234–7.Google Scholar
  40. 40.
    Lonardi C. The passing dilemma in socially invisible diseases: narratives on chronic headache. Soc Sci Med. 2007;65(8):1619–29.Google Scholar
  41. 41.
    Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4(2):167–82.Google Scholar
  42. 42.
    Pierret J. Un objet pour la sociologie de la maladie chronique: la situation de séropositivité au VIH? Sci Soc Santé. 1997;15(4):97–120.Google Scholar
  43. 43.
    Mendès-Leite R, Banens M. Vivre avec le VIH, Calman-Lévy. 2006.Google Scholar
  44. 44.
    Rohleder P, McDermott DT, Cook R. Experience of sexual self-esteem among men living with HIV. J Health Psychol. 2017;22(2):176–85.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Marie Préau
    • 1
    • 2
    Email author
  • Marion Mora
    • 2
    • 3
    • 4
  • Costanza Puppo
    • 1
  • Vanessa Laguette
    • 5
  • Luis Sagaon-Teyssier
    • 2
    • 3
    • 4
  • Faroudy Boufassa
    • 6
  • Laurence Meyer
    • 7
  • Olivier Lambotte
    • 8
    • 9
    • 10
    • 11
  • Bruno Spire
    • 2
    • 3
    • 4
  1. 1.Social Psychology Research Group (EA 4163 GRePS)Lyon 2 University, Lyon UniversityLyonFrance
  2. 2.INSERM U912MarseilleFrance
  3. 3.Aix-Marseille University, UMR_S912, IRDMarseilleFrance
  4. 4.ORS PACAMarseilleFrance
  5. 5.CRP-CO (EA 7273), Picardie Jules Verne UniversityAmiensFrance
  6. 6.Inserm U1018, CESP Centre for Research in Epidemiology and Population Health, Epidemiology of HIV and STI TeamLe Kremlin-BicetreFrance
  7. 7.INSERM SC10 US19VillejuifFrance
  8. 8.Univ Paris Sud, UMR 1184Le Kremlin-BicêtreFrance
  9. 9.CEA, DSV/iMETI, IDMITFontenay-Aux-RosesFrance
  10. 10.INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune DiseasesLe Kremlin-BicêtreFrance
  11. 11.Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie CliniqueLe Kremlin-BicêtreFrance

Personalised recommendations